Opportunity ID: 322436

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-053
Funding Opportunity Title: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 12, 2019
Last Updated Date: Nov 12, 2019
Original Closing Date for Applications: Jan 07, 2023
Current Closing Date for Applications: Jan 07, 2023
Archive Date: Feb 12, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Small businesses
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Private institutions of higher education
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages research projects that focus on innovative research in the isolation and characterization of extracellular vesicles (EVs) and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer. This FOA will promote rigor and reproducibility research in both the isolation of EVs as well as the computational analysis of the cargo carried in these vesicles.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-053.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 322436 Full Announcement-PAR-20-053 -> PAR-20-053-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00259074 Jan 05, 2020 Jan 24, 2022 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00256579 Jan 05, 2020 May 24, 2020 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269737 Oct 28, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277693 Nov 01, 2022 Jan 07, 2023 View

Package 1

Mandatory forms

322436 RR_SF424_2_0-2.0.pdf

322436 PHS398_CoverPageSupplement_5_0-5.0.pdf

322436 RR_OtherProjectInfo_1_4-1.4.pdf

322436 PerformanceSite_2_0-2.0.pdf

322436 RR_KeyPersonExpanded_2_0-2.0.pdf

322436 PHS398_ResearchPlan_4_0-4.0.pdf

322436 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

322436 RR_Budget_1_4-1.4.pdf

322436 RR_SubawardBudget30_1_4-1.4.pdf

322436 PHS398_ModularBudget_1_2-1.2.pdf

322436 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

322436 RR_SF424_2_0-2.0.pdf

322436 PHS398_CoverPageSupplement_4_0-4.0.pdf

322436 RR_OtherProjectInfo_1_4-1.4.pdf

322436 PerformanceSite_2_0-2.0.pdf

322436 RR_KeyPersonExpanded_2_0-2.0.pdf

322436 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

322436 RR_Budget_1_4-1.4.pdf

322436 RR_SubawardBudget30_1_4-1.4.pdf

322436 PHS398_ModularBudget_1_2-1.2.pdf

322436 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 3

Mandatory forms

322436 RR_SF424_5_0-5.0.pdf

322436 PHS398_CoverPageSupplement_5_0-5.0.pdf

322436 RR_OtherProjectInfo_1_4-1.4.pdf

322436 PerformanceSite_4_0-4.0.pdf

322436 RR_KeyPersonExpanded_4_0-4.0.pdf

322436 PHS398_ResearchPlan_4_0-4.0.pdf

322436 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

322436 RR_Budget_3_0-3.0.pdf

322436 RR_SubawardBudget30_3_0-3.0.pdf

322436 PHS398_ModularBudget_1_2-1.2.pdf

322436 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 4

Mandatory forms

322436 RR_SF424_5_0-5.0.pdf

322436 PHS398_CoverPageSupplement_5_0-5.0.pdf

322436 RR_OtherProjectInfo_1_4-1.4.pdf

322436 PerformanceSite_4_0-4.0.pdf

322436 RR_KeyPersonExpanded_4_0-4.0.pdf

322436 PHS398_ResearchPlan_5_0-5.0.pdf

322436 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

322436 RR_Budget_3_0-3.0.pdf

322436 RR_SubawardBudget30_3_0-3.0.pdf

322436 PHS398_ModularBudget_1_2-1.2.pdf

322436 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T10:38:46-05:00

Share This Post, Choose Your Platform!

About the Author: